MYD88 and influenza: Our previous studies, which showed that protection against influenza infection elicited by the rASP-1-adjuvanted IIV3 vaccine is independent of MyD88, led us to hypothesize that type I IFN, a critical element of anti-viral responses (32–34) has a significant role for this protection.